Karo Pharma postpones the Annual General Meeting to 25 May, 2020
The board of directors of Karo Pharma Aktiebolag (”Karo Pharma”) has resolved to postpone the Annual General Meeting to 25 May, 2020. The previously communicated date for the meeting was 29 April 2020. The delay is due to the increased concern of the spread of COVID-19 with the related safety of the participants. A notice will be sent out four weeks in advance of the meeting. For additional information, please contact: Christoffer Lorenzen, CEO, +4673-501 76 20, christoffer.lorenzen@karopharma.com Jon Johnsson, CFO, +4673-507 88 61, jon.johnsson@karopharma.com About Karo Pharma